Cytokinetics, Incorporated (CYTK)

36.30
0.73 1.97
NASDAQ
Prev Close 37.03
Open 37.03
Day Low/High 36.27 / 37.45
52 Wk Low/High 14.89 / 39.46
Volume 472.82K
Exchange NASDAQ
Shares Outstanding 83.51B
Market Cap 3.02B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Cutting Edge Biotech Cytokinetics Could Double in Price

Cutting Edge Biotech Cytokinetics Could Double in Price

Let's check the charts and indicators.

Cytokinetics Shares Plunge on Study Results for ALS Drug -- Biotech Movers

Cytokinetics Shares Plunge on Study Results for ALS Drug -- Biotech Movers

The South San Francisco, Calif.-based firm said its Phase 3 study of tirasemtiv in patients with amyotrophic lateral sclerosis did not achieve primary or secondary endpoints.

These Stocks Are Trending Up With Monster Volume

These Stocks Are Trending Up With Monster Volume

Let's take a look at several stocks that are experiencing unusual volume activity.

Stocks Up as Deals Get Done

Stocks Up as Deals Get Done

Stocks are higher on deals as Microsoft buys Nokia and Jarden buys Yankee Candle Company.

TSRX, CYTK, ARRY: 3 Stocks on TV

TSRX, CYTK, ARRY: 3 Stocks on TV

StockMarketMentor.com founder Dan Fitzpatrick details how to play three stocks Jim Cramer discussed on CNBC's "Mad Money" last night.